You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. A CD8+ T cell diagnostic to identify children with pulmonary tuberculosis

    SBC: ViTi, Inc            Topic: NIAID

    DESCRIPTION provided by applicant Tuberculosis TB disease which results from infection with Mycobacterium tuberculosis Mtb is a leading cause of infectious morbidity and mortality in children andlt years old worldwide In TB endemic regions in which the vast majority of the worldandapos s annual million adult cases of TB disease reside children andlt years old account for ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  2. rAAV5-hCNGB3 Gene Therapy for Achromatopsia: Safety and Efficacy in a Dog Model

    SBC: APPLIED GENETIC TECHNOLOGIES CORPORATION            Topic: N

    DESCRIPTION provided by applicant Complete achromatopsia is an autosomal recessive inherited congenital disorder of retinal cone photoreceptors Patients with complete achromatopsia experience extreme light sensitivity and daytime blindness and best visual acuity under non bright light conditions is usually or worse and generally stable over time In addition to poor acuity hypersensit ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  3. Rapid Identification of Pathogenic Bacteria and Sepsis Diagnosis

    SBC: ISENSE, LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): Sepsis is the tenth-leading cause of death in the United States and the second-leading cause of death in the intensive care unit (ICU). Sepsis kills over 215,000 Americans each year - more than breast cancer, lung cancer, and prostate cancer combined. Rapid identification and determination of antibiotic susceptibility is critical fo effective treatment of infec ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  4. Ontology-Based Knowledge and Belief Management System

    SBC: INFOTECH SOFT, INC.            Topic: NIGMS

    DESCRIPTION provided by applicant Dramatic advances in the development of biomedical ontologies hold the promise of a deeper and clearer understanding of the molecular and genetic aspects that affect human health Biomedical data and knowledge stored in ontologies and databases have the potential to empower researchers in the life sciences to access and find conclusive evidence that can be translat ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  5. A research and drug development tool for the real time in vitro study of single c

    SBC: KYTARO, INC.            Topic: 100

    DESCRIPTION In this SBIR Phase II PicoCal will develop a high throughput apparatus to measure changes in cell adhesion at the level of individual receptor ligand interactions in real time This tool finds critical applications in research and drug development and would allow researchers to study and manipulate adhesion by bioactive compounds to promote or inhibit physiological processes There is a ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  6. GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine

    SBC: NANOTHERAPEUTICS, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Noroviruses are a group of enteropathogenic viruses belonging to the taxonomic family Caliciviridae which causes approximately of epidemic non bacterial outbreaks of gastroenteritis around the world and may be responsible for of all foodborne outbreaks of gastroenteritis in the US In developing countries according to a estimate by CDC researchers up to children le ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Long-Acting G-CSF Analog for Treating ARS

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: NIAID

    DESCRIPTION provided by applicant Development of radiological nuclear medical countermeasures to treat Acute Radiation Syndrome ARS is a high priority research area for NIAID Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure often resulting i death Granulocyte colony stimulating ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Remote Anger and Stress Management (M-SAT)

    SBC: Design Interactive, Inc            Topic: OSD11H13

    Concern has been raised over the prevalence of behavioral health disorders in military personnel returning from deployment to the Middle East. While not appearing as an overt physical injury, disruptions of a psychological nature are often as debilitating, and there is an increasing need for support tools. Such tools should allow for standardized tracking, monitoring, and mitigation of anger and ...

    SBIR Phase II 2013 Department of DefenseDefense Health Program
  9. Serious Game for Continuity of Care Training

    SBC: Vcom3D, Inc.            Topic: OSD10H08

    For this Phase II SBIR project, Vcom3D proposes a Serious Game for Continuity of Care that trains combat physicians in making critical medical decisions when faced with a multiple-casualty, multi-trauma incident. The Serious Game for Continuity of Care will provide a fast-paced learning environment that will require the selective attention to numerous, competing visual and aural cues and delegatio ...

    SBIR Phase II 2013 Department of DefenseDefense Health Program
  10. Return on Investment Tool for Effective Medical Training (RITE-MT)

    SBC: Design Interactive, Inc            Topic: OSD11H19

    The Return on Investment Tool for Effective Medical Training (RITE-MT) tool aims to substantially improve the decision making process of training system requirements and acquisition professionals by objectively quantifying training system Return On Training Investment (ROTI) based on lifecycle cost, schedule and performance impacts. RITE-MT uses a training needs-based approach to ROTI which incorp ...

    SBIR Phase II 2013 Department of DefenseDefense Health Program
US Flag An Official Website of the United States Government